- One of the most fundamental investing principles is to maintain strategic asset allocation and periodically rebalance by trimming assets that have outperformed and adding to those that have lagged. While simple in theory, it is difficult in practice because most investors chase rising assets and avoid underperformers, whereas disciplined rebalancing requires a strategy-driven and mature approach to long-term investing.
- JPMorgan Chase & Co. expects markets to remain volatile in the near term amid AI-related disruptions, lack of double-digit growth and rupee weakness impacting FII flows. The firm remains cautiously optimistic on India with an overweight stance, while preferring coal, coal-related businesses and renewable energy names.
- India faces rising food inflation risks as West Asia tensions push fertiliser and import costs higher. Urea bids have surged close to $1,000 per ton amid supply disruption near the Strait of Hormuz. Deloitte warns of imported inflation in edible oils and pulses, while CRISIL expects fertiliser output to drop 10–15%. The Food and Agriculture Organization also noted global food prices have risen for a second consecutive month with further upside risks.
- Denta Water and Infra Solutions reported strong 9MFY26 performance with revenue up 30.8% YoY to Rs.1,950.67 Mn and EBITDA up 34% YoY to Rs.708.47 Mn. The company secured Rs.106 crore water infrastructure orders in Karnataka covering sewage treatment and sewerage projects. It paid 25% dividend for FY25. Stock looks attractive at Rs.301 vs 52-week high of Rs.479.
- Jyoti Ltd. posted 87% higher PAT of Rs.15 crore in 9MFY26 vs Rs.8.04 crore earlier. It secured orders of Rs.6.45 crore from Indian Oil Corporation for HV switchboards and Rs.40.77 crore from GETCO for 11KV VCB panels. Technology transfer deal for electric bus drive motors is another positive trigger. Stock looks attractive at Rs.70 vs lifetime high of Rs.208.
- Morepen Laboratories secured a multi-year CDMO contract worth Rs.825 crore from a global pharma major. Its API facility in Himachal Pradesh cleared USFDA inspection with NIL Form 483 observations. The company has reserves of Rs.1,047 crore vs equity of Rs.110 crore. Stock looks attractive at Rs.42 vs lifetime high of Rs.222.
